BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37163949)

  • 21. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.
    Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X
    Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoplasmic Reticulum Stress Promotes Autophagy and Apoptosis and Reduces Chemotherapy Resistance in Mutant p53 Lung Cancer Cells.
    Gan PP; Zhou YY; Zhong MZ; Peng Y; Li L; Li JH
    Cell Physiol Biochem; 2017; 44(1):133-151. PubMed ID: 29130967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of carboplatin on the proliferation and apoptosis of ovarian cancer cells through mTOR/p70s6k signaling pathway.
    Zhou H; Zhao H; Liu H; Xu X; Dong X; Zhao E
    J BUON; 2018; 23(6):1732-1738. PubMed ID: 30610801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of novel 1,3,5-triazine derivatives as potent inhibitor of cervical cancer via dual inhibition of PI3K/mTOR.
    Hu J; Zhang Y; Tang N; Lu Y; Guo P; Huang Z
    Bioorg Med Chem; 2021 Feb; 32():115997. PubMed ID: 33440319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constitutive activation of p70 S6 kinase is associated with intrinsic resistance to cisplatin.
    Dhar R; Basu A
    Int J Oncol; 2008 May; 32(5):1133-7. PubMed ID: 18425342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of tertiary amide derivatives incorporating benzothiazole moiety as anti-gastric cancer agents in vitro via inhibiting tubulin polymerization and activating the Hippo signaling pathway.
    Song J; Gao QL; Wu BW; Zhu T; Cui XX; Jin CJ; Wang SY; Wang SH; Fu DJ; Liu HM; Zhang SY; Zhang YB; Li YC
    Eur J Med Chem; 2020 Oct; 203():112618. PubMed ID: 32682200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. mTOR, p70S6K, AKT, and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids.
    Gagliano T; Bellio M; Gentilin E; Molè D; Tagliati F; Schiavon M; Cavallesco NG; Andriolo LG; Ambrosio MR; Rea F; Degli Uberti E; Zatelli MC
    Endocr Relat Cancer; 2013 Aug; 20(4):463-75. PubMed ID: 23653462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular docking, anti-proliferative activity and induction of apoptosis in human liver cancer cells treated with androstane derivatives: Implication of PI3K/AKT/mTOR pathway.
    Kattan SW; Nafie MS; Elmgeed GA; Alelwani W; Badar M; Tantawy MA
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105604. PubMed ID: 31982513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A steroidal saponin isolated from Allium chinense simultaneously induces apoptosis and autophagy by modulating the PI3K/Akt/mTOR signaling pathway in human gastric adenocarcinoma.
    Xu J; Zhang M; Lin X; Wang Y; He X
    Steroids; 2020 Sep; 161():108672. PubMed ID: 32485185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delicaflavone induces autophagic cell death in lung cancer via Akt/mTOR/p70S6K signaling pathway.
    Sui Y; Yao H; Li S; Jin L; Shi P; Li Z; Wang G; Lin S; Wu Y; Li Y; Huang L; Liu Q; Lin X
    J Mol Med (Berl); 2017 Mar; 95(3):311-322. PubMed ID: 27838742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SB365 inhibits angiogenesis and induces apoptosis of hepatocellular carcinoma through modulation of PI3K/Akt/mTOR signaling pathway.
    Hong SW; Jung KH; Lee HS; Choi MJ; Son MK; Zheng HM; Hong SS
    Cancer Sci; 2012 Nov; 103(11):1929-37. PubMed ID: 22909393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BF12, a Novel Benzofuran, Exhibits Antitumor Activity by Inhibiting Microtubules and the PI3K/Akt/mTOR Signaling Pathway in Human Cervical Cancer Cells.
    Gao Y; Ma C; Feng X; Liu Y; Haimiti X
    Chem Biodivers; 2020 Mar; 17(3):e1900622. PubMed ID: 31951313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway.
    Xu R; Zhang Y; Li A; Ma Y; Cai W; Song L; Xie Y; Zhou S; Cao W; Tang X
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3-Arylamino-quinoxaline-2-carboxamides inhibit the PI3K/Akt/mTOR signaling pathways to activate P53 and induce apoptosis.
    Chen NY; Lu K; Yuan JM; Li XJ; Gu ZY; Pan CX; Mo DL; Su GF
    Bioorg Chem; 2021 Sep; 114():105101. PubMed ID: 34175723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deciphering downstream gene targets of PI3K/mTOR/p70S6K pathway in breast cancer.
    Heinonen H; Nieminen A; Saarela M; Kallioniemi A; Klefström J; Hautaniemi S; Monni O
    BMC Genomics; 2008 Jul; 9():348. PubMed ID: 18652687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autophagic Activation and Decrease of Plasma Membrane Cholesterol Contribute to Anticancer Activities in Non-Small Cell Lung Cancer.
    Hsu JL; Leu WJ; Zhong NS; Guh JH
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel hybrid of 3-benzyl coumarin seco-B-ring derivative and phenylsulfonylfuroxan induces apoptosis and autophagy in non-small-cell lung cancer.
    Dong M; Ye T; Bi Y; Wang Q; Kuerban K; Li J; Feng M; Wang K; Chen Y; Ye L
    Phytomedicine; 2019 Jan; 52():79-88. PubMed ID: 30599915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Synergistic Anti-Cancer Effects of NVP-BEZ235 and Regorafenib in Hepatocellular Carcinoma.
    Yu CC; Huang SY; Chang SF; Liao KF; Chiu SC
    Molecules; 2020 May; 25(10):. PubMed ID: 32466169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiproliferative Activity of Carnosic Acid is Mediated via Inhibition of Cell Migration and Invasion, and Suppression of Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
    Zhao L; Zhang J; Fan Y; Li Y
    Med Sci Monit; 2019 Oct; 25():7864-7871. PubMed ID: 31631173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of rapamycin treatment in human seminoma TCam-2 cells through inhibition of G1-S transition.
    Onel T; Erdogan CS; Aru B; Yildirim E; Demirel GY; Yaba A
    Naunyn Schmiedebergs Arch Pharmacol; 2023 May; 396(5):1009-1018. PubMed ID: 36598515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.